EGFR and colorectal carcinoma: Berberine also exerts antiproliferative activity by participating in inflammatory response-driven epidermal growth factor receptor (EGFR) signaling pathway, thereby preventing the progression of colitis-associated CRC (Li D. et al., 2017).